Heart Transplant Recipients May Benefit From New Noninvasive Test To Assess Organ Rejection Risk
Natera’s Prospera Heart Assessment is a simple blood test that can evaluate the risk of the body rejecting the donor organ after transplant surgery. It could potentially replace invasive biopsy, the current standard of care.
You may also be interested in...
A bipartisan group of legislators in the US House of Representatives wants to stop the Centers for Medicare & Medicaid Services (CMS) from finalizing proposed cuts to treatments for cancer, kidney failure, artery disease and other conditions.
US lawmakers issued a bipartisan resolution in recognition of the first Telehealth Awareness Week sponsored by the American Telemedicine Association. The resolution illustrates telehealth’s broad support and appeal.
The US Food and Drug Administration has taken additional steps to ensure mutations of the COVID-19 virus do not negatively impact the efficacy of tests.